Key statistics
On Thursday, Actinium Pharmaceuticals Inc (7AY1:BER) closed at 1.69, 9.90% above its 52-week low of 1.54, set on Sep 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.61 |
---|---|
High | 1.69 |
Low | 1.61 |
Bid | 1.54 |
Offer | 1.83 |
Previous close | 1.69 |
Average volume | 2.06k |
---|---|
Shares outstanding | 31.15m |
Free float | 30.52m |
P/E (TTM) | -- |
Market cap | 55.45m USD |
EPS (TTM) | -1.52 USD |
Data delayed at least 15 minutes, as of Sep 19 2024 19:21 BST.
More ▼
Press releases
- Actinium Provides Regulatory Update on Planned BLA Filing and Future Plans for Iomab-B in the U.S.
- Actinium Expands Patent Coverage Over Iomab-ACT, its Next-Generation Targeted Radiotherapy Conditioning Agent, for Gene Edited Stem Cell-Based Therapies for Non-Malignant Indications
- Actinium Announces FDA Clearance of Iomab-ACT Targeted Conditioning IND Application for Sickle Cell Disease Patients Undergoing Bone Marrow Transplant in Collaboration with Columbia University
- Actinium Pharmaceuticals to Present at the 3rd Annual Targeted Radiopharmaceuticals Summit US